FLDM
NASDAQFluidigm Corporation
Latest news
25 items- NEWSNo More Free COVID-19 At-Home Tests, Federal Government SaysCNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional authorization for an extension. "Ordering through this program will be suspended on Friday, September 2, because Congress hasn't provided additional funding to replenish the nation's stockpile of tests," a message on the federal government's COVID-19 website reads. According to an earlier CNBC report, Senate Republicans and Democrats have reportedly reached a tentative deal on $10 billion in additional COVID-19 funding to shore up the nation's pandemic preparedness. Related: White House Warns It Cannot Afford COVID-19 Related Solutions If Case
- SECFluidigm Corporation filed SEC Form 8-K: Leadership Update8-K - STANDARD BIOTOOLS INC. (0001162194) (Filer)
- SECFluidigm Corporation filed SEC Form 8-K: Leadership Update8-K - STANDARD BIOTOOLS INC. (0001162194) (Filer)
- INSIDERSEC Form 4: Colston Bill was granted 30,914 shares, increasing direct ownership by 109% to 59,288 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- INSIDERSEC Form 4: Burbach Gerhard F was granted 30,914 shares, increasing direct ownership by 47% to 96,827 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- INSIDERSEC Form 4: Madaus Martin D was granted 30,914 shares, increasing direct ownership by 195% to 46,766 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- INSIDERSEC Form 4: Witney Frank was granted 30,914 shares, increasing direct ownership by 195% to 46,766 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- INSIDERSEC Form 4: Paya Carlos V was granted 30,914 shares, increasing direct ownership by 44% to 100,468 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- INSIDERSEC Form 4: Casdin Eli was granted 30,914 shares, increasing direct ownership by 195% to 46,766 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- INSIDERSEC Form 4: Clague Laura was granted 30,914 shares, increasing direct ownership by 65% to 78,415 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- SECFluidigm Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - STANDARD BIOTOOLS INC. (0001162194) (Filer)
- INSIDERSEC Form 4: Caligan Partners Lp bought $170,000 worth of shares (100,000 units at $1.70)4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- 13D/GSEC Form SC 13D/A filed by Fluidigm Corporation (Amendment)SC 13D/A - STANDARD BIOTOOLS INC. (0001162194) (Subject)
- INSIDERSEC Form 4: Caligan Partners Lp bought $879,000 worth of shares (450,000 units at $1.95)4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- INSIDERSEC Form 4: Khadder Nicholas was granted 3,341 shares, increasing direct ownership by 3% to 100,480 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- SECSEC Form 424B3 filed by Fluidigm Corporation424B3 - STANDARD BIOTOOLS INC. (0001162194) (Filer)
- SECSEC Form EFFECT filed by Fluidigm CorporationEFFECT - STANDARD BIOTOOLS INC. (0001162194) (Filer)
- INSIDERSEC Form 4: Kreger Bradley Allen converted options into 42,280 shares and covered exercise/tax liability with 14,431 shares, increasing direct ownership by 31% to 119,157 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- INSIDERSEC Form 4: Khadder Nicholas covered exercise/tax liability with 14,161 shares and converted options into 28,909 shares, increasing direct ownership by 18% to 97,139 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- INSIDERSEC Form 4: Jog Vikram converted options into 41,901 shares and covered exercise/tax liability with 14,361 shares, increasing direct ownership by 21% to 161,751 units4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- SECSEC Form S-3 filed by Fluidigm CorporationS-3 - STANDARD BIOTOOLS INC. (0001162194) (Filer)
- INSIDERSEC Form 4: Caligan Partners Lp bought $1,406,715 worth of shares (488,350 units at $2.88)4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
- SECSEC Form 10-Q filed by Fluidigm Corporation10-Q - STANDARD BIOTOOLS INC. (0001162194) (Filer)
- 13D/GSEC Form SC 13D/A filed by Fluidigm Corporation (Amendment)SC 13D/A - STANDARD BIOTOOLS INC. (0001162194) (Subject)
- INSIDERSEC Form 4: Caligan Partners Lp bought $1,075,574 worth of shares (400,000 units at $2.69)4 - STANDARD BIOTOOLS INC. (0001162194) (Issuer)
FLDM FAQ
6 questionsWhat does Fluidigm Corporation do?
Fluidigm Corporation creates, manufactures, and markets technologies and life sciences tools worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, Hyperion tissue imager, and flow conductor; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow., as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system...Where does FLDM stock trade?
Fluidigm Corporation (FLDM) is listed on NASDAQ.What sector and industry is FLDM in?
Fluidigm Corporation operates in the Capital Goods sector, Biotechnology: Laboratory Analytical Instruments industry.When did Fluidigm Corporation go public?
Fluidigm Corporation (FLDM) completed its IPO in 2011.What companies are similar to FLDM?
Notable peers in the same industry include A (Agilent Technologies Inc.), WAT (Waters Corporation), MTD (Mettler-Toledo International Inc.), PKI (PerkinElmer Inc.), RVTY (Revvity Inc.). Compare FLDM side-by-side with any of them on Quantisnow.How can I track FLDM on Quantisnow?
Quantisnow aggregates Fluidigm Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow FLDM to receive live email and push alerts on every new disclosure.